What's new

Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised

Feb 12, 2025 - 16:22
 0
Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Dafiro HCT, amlodipine besilate,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Larry Tabak, NIH’s longtime second-in-command, to retire  

Next Article

Human medicines European public assessment report (EPAR): Copalia HCT, amlodipin...

Related Posts

EMEA-003498-PIP01-23

EMEA-003498-PIP01-23

Mar 7, 2025  0

Orphan designation: [4-(Methyl-1H-pyrazol-4-yl)-benzyl]-(6[7-(3-pyrrolidin-1-yl-propoxy)-imidazo[1,2-a]pyridin-3-yl]-pyrimidin-4-yl]-amine Treatment of gastrointestinal stromal tumours, 16/01/2025 Positive

Orphan designation: [4-(Methyl-1H-pyrazol-4-yl)-benzyl]...

Feb 20, 2025  0

SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2024, 10:00 (CEST) to 14 October 2024, 12:00 (CEST)

SPOR and xEVMPD Stakeholder Engagement Webinars : Subst...

Apr 1, 2025  0